Quantitative risk-benefit analysis of natalizumab

R. G. Holloway; J. P. Thompson; K. Noyes; R. R. Dorsey; S. R. Schwid

doi:10.1212/01.wnl.0000347020.85704.36

Quantitative risk-benefit analysis of natalizumab

R. G. Holloway
, J. P. Thompson
, K. Noyes
, R. R. Dorsey
, S. R. Schwid

Department of Epidemiology and Environmental Health

Rochester NY

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	1791-1792
Number of pages	2
Journal	Neurology
Volume	72
Issue number	20
DOIs	https://doi.org/10.1212/01.wnl.0000347020.85704.36
State	Published - May 19 2009

Access to Document

10.1212/01.wnl.0000347020.85704.36

Cite this

@article{31a3882bb3a44036b55653d7ed536d15,

title = "Quantitative risk-benefit analysis of natalizumab",

author = "Holloway, \{R. G.\} and Thompson, \{J. P.\} and K. Noyes and Dorsey, \{R. R.\} and Schwid, \{S. R.\}",

year = "2009",

month = may,

day = "19",

doi = "10.1212/01.wnl.0000347020.85704.36",

language = "English",

volume = "72",

pages = "1791--1792",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "20",

}

TY - JOUR

T1 - Quantitative risk-benefit analysis of natalizumab

AU - Holloway, R. G.

AU - Thompson, J. P.

AU - Noyes, K.

AU - Dorsey, R. R.

AU - Schwid, S. R.

PY - 2009/5/19

Y1 - 2009/5/19

UR - https://www.scopus.com/pages/publications/66149151777

U2 - 10.1212/01.wnl.0000347020.85704.36

DO - 10.1212/01.wnl.0000347020.85704.36

M3 - Letter

C2 - 19451538

AN - SCOPUS:66149151777

SN - 0028-3878

VL - 72

SP - 1791

EP - 1792

JO - Neurology

JF - Neurology

IS - 20

ER -

Quantitative risk-benefit analysis of natalizumab

Access to Document

Other files and links

Fingerprint

Cite this